Treatment of a patient in a relapse after bone marrow transplantation for acute lymphoblastic leukemia with the systemic administration of allogeneic lymphokine-activated killer cells and recombinant interleukin-2.
Komori
T
T
Sugiyama
H
H
Ogawa
H
H
Oka
Y
Y
Miyake
S
S
Soma
T
T
Tani
Y
Y
Minami
Y
Y
Kunisada
K
K
Masaoka
T
T
D000328:Adult; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012008:Recurrence
D007376:Interleukin-2; D011994:Recombinant Proteins; D007770:L-Lactate Dehydrogenase